1. Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O et al Global, Regional, and National Cancer Incidence, Mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol 2019
2. Hochster HS, O'Reilly EM, Ajani JA, Venook AP (2007) Section III: Treatment of advanced gastrointestinal cancers. Gastrointest Cancer Res 1(6 Suppl):S8–S12
3. Kennedy-Martin T, Curtis S, Faries D, Robinson S, Johnston J (2015) A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results. Trials 16:495
4. He Z, Chen Z, George T, Lipori G, Bian J (2016) Assessing the population representativeness of colorectal cancer treatment clinical trials. 2970–3 p
5. Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Gibbons MC et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 112(2):228–242